kynurenine has been researched along with Acute Relapsing Multiple Sclerosis in 4 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansi, J | 1 |
| Koliamitra, C | 1 |
| Bloch, W | 1 |
| Joisten, N | 1 |
| Schenk, A | 1 |
| Watson, M | 1 |
| Kool, J | 1 |
| Langdon, D | 1 |
| Dalgas, U | 1 |
| Kesselring, J | 1 |
| Zimmer, P | 1 |
| Herman, S | 1 |
| Åkerfeldt, T | 1 |
| Spjuth, O | 1 |
| Burman, J | 1 |
| Kultima, K | 1 |
| Amirkhani, A | 1 |
| Rajda, C | 1 |
| Arvidsson, B | 1 |
| Bencsik, K | 1 |
| Boda, K | 1 |
| Seres, E | 1 |
| Markides, KE | 1 |
| Vécsei, L | 1 |
| Bergquist, J | 1 |
| Frankish, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis: A Pilot Study.[NCT05562414] | 30 participants (Anticipated) | Interventional | 2022-10-01 | Recruiting | |||
| The Influence of High-Intensity Interval Training Compared to Moderate Continuous Training on Cardiorespiratory Fitness, Symptom Improvement, and Disease-specific Biomarkers in Primary Progressive Multiple Sclerosis[NCT05229861] | 61 participants (Anticipated) | Interventional | 2022-05-10 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for kynurenine and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training.
Topics: Adult; Endurance Training; Exercise Therapy; Female; Humans; Kynurenine; Male; Middle Aged; Multiple | 2018 |
Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training.
Topics: Adult; Endurance Training; Exercise Therapy; Female; Humans; Kynurenine; Male; Middle Aged; Multiple | 2018 |
Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training.
Topics: Adult; Endurance Training; Exercise Therapy; Female; Humans; Kynurenine; Male; Middle Aged; Multiple | 2018 |
Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training.
Topics: Adult; Endurance Training; Exercise Therapy; Female; Humans; Kynurenine; Male; Middle Aged; Multiple | 2018 |
Interferon-beta affects the tryptophan metabolism in multiple sclerosis patients.
Topics: Adjuvants, Immunologic; Adult; Chromatography; Female; Humans; Interferon-beta; Kynurenic Acid; Kynu | 2005 |
2 other studies available for kynurenine and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing⁻Remitting Multiple Sclerosis.
Topics: Adult; Case-Control Studies; Female; Humans; Kynurenine; Male; Metabolome; Middle Aged; Multiple Scl | 2019 |
Tryptophan metabolite improves symptoms in MS model.
Topics: Animals; Disease Models, Animal; Kynurenine; Mice; Multiple Sclerosis, Relapsing-Remitting; Neuritis | 2006 |